The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers

NCT02361138 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: SHR3824
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.